Research at TMDU
Contributing to Total Healthcare through research with social impact.
Tokyo Medical and Dental University (TMDU) was selected as a “Designated National University Corporation” by Koichi Hagiuda, Minister of Education, Culture, Sports, Science and Technology on October 15, 2020. This attests to the recognition that TMDU is one of the foremost national universities in Japan with the potential to compete with the world's leading universities. We have been starting to act as a designated national university corporation since April 2022. Of the 10 designated national universities, TMDU is the only one specialized in the medical field. Reflecting this, ourmission is not only to produce excellent research results, but also to realize Total Healthcare for the world and humankind across the generations.
Convergence Science, cross-disciplinary research, is a powerful strategy for creating innovations that realize total healthcare. In 2021, since the COVID-19 pandemic limited opportunities for interdisciplinary research beyond the
university, we supported cross-departmental research within the university. In a statement on April 1, 2021 (https://www.tmd.ac.jp/english/outline/office_of_the_president/20210401_1/), President Tanaka quoted playwright Maurice
Maeterlinck’s The Blue Bird, the blue bird of happiness is at home rather than far away. TMDU is a university focusing on medicine and dentistry, but it also includes the Medical Research Institute focused on science, the Institute of
Biomaterials and Bioengineering, and the M&D Data Science Center. Our strategy is to promote joint research across multiple fi elds.
From 2022, as promised by President Tanaka in his message on April 1, 2022 (https://www.tmd.ac.jp/english/outline/office_of_the_president/20220401_1/), we will pursue not only on-campus but also off-campus interdisciplinary research. We will promote off-campus interdisciplinary research based on a coalition of four universities — Hitotsubashi University, Tokyo University of Foreign Studies, Tokyo Institute of Technology, and TMDU; a joint research center network formed by the Medical Research Institute and the Institute of Biomaterials and Bioengineering under a program of the Ministry of Education, Science and Technology; medical data utilization in collaboration with TMDU-affiliated hospitals; and industry-academia collaboration centering on TMDU Innovation Park (TIP). We will develop interdisciplinary research not only in Japan but also overseas.
Our research policies are "Academic Freedom," "Academic Integrity," and "Social Impact." We aim to realize total healthcare through research that has a social impact, while defending academic integrity through an unswerving commitment to free-fl owing intellectual inquiry.
Convergence Science, cross-disciplinary research, is a powerful strategy for creating innovations that realize total healthcare. In 2021, since the COVID-19 pandemic limited opportunities for interdisciplinary research beyond the
university, we supported cross-departmental research within the university. In a statement on April 1, 2021 (https://www.tmd.ac.jp/english/outline/office_of_the_president/20210401_1/), President Tanaka quoted playwright Maurice
Maeterlinck’s The Blue Bird, the blue bird of happiness is at home rather than far away. TMDU is a university focusing on medicine and dentistry, but it also includes the Medical Research Institute focused on science, the Institute of
Biomaterials and Bioengineering, and the M&D Data Science Center. Our strategy is to promote joint research across multiple fi elds.
From 2022, as promised by President Tanaka in his message on April 1, 2022 (https://www.tmd.ac.jp/english/outline/office_of_the_president/20220401_1/), we will pursue not only on-campus but also off-campus interdisciplinary research. We will promote off-campus interdisciplinary research based on a coalition of four universities — Hitotsubashi University, Tokyo University of Foreign Studies, Tokyo Institute of Technology, and TMDU; a joint research center network formed by the Medical Research Institute and the Institute of Biomaterials and Bioengineering under a program of the Ministry of Education, Science and Technology; medical data utilization in collaboration with TMDU-affiliated hospitals; and industry-academia collaboration centering on TMDU Innovation Park (TIP). We will develop interdisciplinary research not only in Japan but also overseas.
Our research policies are "Academic Freedom," "Academic Integrity," and "Social Impact." We aim to realize total healthcare through research that has a social impact, while defending academic integrity through an unswerving commitment to free-fl owing intellectual inquiry.
